Reuters ranks Hebrew University among world’s 100 ‘Most Innovative Universities’
November 28, 2017
Hebrew University’s Yissum Research Development Company, which brings discoveries to market, holds 10,000 patents for 2,800 inventions, and has licensed more than 900 technologies and launched 125 startups
Jerusalem, November 27, 2017 — The Hebrew University of Jerusalem has been ranked the 82nd most innovative university in the world in Reuters’ annual ranking of the World’s Most Innovative Universities. The Hebrew University was the top-ranked institution in Israel, followed by Tel Aviv University at 88 and Technion-Israel Institute of Technology at 89. The Hebrew University climbed 14 points from last year, when it was ranked 94th most innovative.
Reuters is an international news and information provider reaching more than one billion people every day. The Reuters analysis identifies the educational institutions doing the most to advance science, invent new technologies and power new markets and industries. The ranking is based on a number of indicators, including patent filings and research paper citations.
Reuters cited the Hebrew University’s technology transfer company, Yissum Research Development Company, as bringing students’ and researchers’ technologies and discoveries to market, with 10,000 registered patents covering 2,800 inventions, more than 900 licensed technologies, and 125 startups launched.
“We are gratified by this recognition of the Hebrew University’s innovation leadership,” said Prof. Asher Cohen, President of the Hebrew University of Jerusalem. “A century ago this heritage of innovation began with our founding by the likes of Albert Einstein, Sigmund Freud and Martin Buber. More than half a century ago, we established Yissum to turn breakthrough academic research into commercial applications. And today, this culture of innovation continues through the efforts and excellence of our students, faculty and staff, whose work is creating a better world for people everywhere.”
“The Hebrew University of Jerusalem’s Yissum Research Development Co brings students’ and researchers’ technologies and discoveries to market,” said the Reuters profile. “Administrators claim that products based on its commercialized patents generate more than $2 billion a year in sales. Successful developments include the drug Exelon, used to treat Alzheimer’s disease; Doxil, for ovarian cancer; and Mobileye, a collision-warning system for vehicles.”
“These highly successful innovations are excellent examples of the kind of transformational research that continuously originates from the Hebrew University,” said Dr. Yaron Daniely, CEO & President of Yissum. “Our mission as one of the first technology transfer companies ever created is to ensure that Hebrew University’s groundbreaking research continues to attract entrepreneurial and industry support, and translates to solutions addressing challenges faced across the globe today.”
Yissum is the technology transfer company of The Hebrew University of Jerusalem. Founded in 1964, it is the third company of its kind to be established, and today serves as a bridge between cutting-edge academic research and a global community of entrepreneurs, investors, and industry organizations. For more information, please visit www.yissum.co.il.
The Hebrew University of Jerusalem is Israel’s leading academic and research institution, where science and knowledge are advanced for the benefit of humankind. The Hebrew University produces one third of all civilian research in Israel. For more information, please visit http://new.huji.ac.il/en.